{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T01:34:30Z","timestamp":1720316070295},"reference-count":17,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FIS","award":["99\/0051-01"],"award-info":[{"award-number":["99\/0051-01"]}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.vaccine.2013.03.035","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:45:19Z","timestamp":1365122719000},"page":"2417-2419","source":"Crossref","is-referenced-by-count":2,"title":["Impaired cellular immune response to tetanus toxoid but not to cytomegalovirus in effectively HAART-treated HIV-infected children"],"prefix":"10.1016","volume":"31","author":[{"given":"Laia","family":"Alsina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.03.035_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00431-006-0184-2","article-title":"Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)","volume":"166","author":"Ching","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1468-1293.2007.00445.x","article-title":"Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells","volume":"8","author":"French","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006454-200301000-00016","article-title":"Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children","volume":"22","author":"Hainaut","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0020","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1542\/peds.111.6.e641","article-title":"Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy","volume":"111","author":"Melvin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(04)01106-5","article-title":"Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children","volume":"4","author":"Obaro","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/jis386","article-title":"Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy","volume":"206","author":"Abzug","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1468-1293.2011.00982.x","article-title":"Guidance on vaccination of HIV-infected children in Europe","volume":"13","author":"Menson","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2010.07.018","article-title":"Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome","volume":"126","author":"Al-Sukaiti","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0050","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/CDLI.5.6.894-896.1998","article-title":"Aging and the immune response to tetanus toxoid: diminished frequency and level of cellular immune reactivity to antigenic stimulation","volume":"5","author":"Schatz","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2005.05.016","article-title":"Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection","volume":"116","author":"Rosenblatt","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jim.2005.07.014","article-title":"Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR","volume":"305","author":"Tassignon","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0065","first-page":"1","article-title":"Revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"13","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0070","series-title":"Module 3: Tetanus Update","first-page":"63","article-title":"The immunological basis for immunization series","author":"Borrow","year":"2006"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0b013e318189a7af","article-title":"The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression","volume":"49","author":"Darwich","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.coi.2012.05.004","article-title":"Immunosenescence and HIV","volume":"24","author":"Deeks","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2013.03.035_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/420931","article-title":"Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy","volume":"39","author":"Weinberg","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T23:04:07Z","timestamp":1595631847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13003708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0264410X13003708"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}